About 6 results found for searched term "TAPI-2" (0.135 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6216 | TAPI-2 | MMP |
| TAPI-2 is a broad-spectrum inhibitor of matrix metalloprotease (MMP), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM), with an IC50 of 20±10 μM for MMP. | ||
| M30492 | (R)-TAPI-2 | Others |
| (R)-TNF Protease Inhibitor 2 | ||
| (R)-TAPI-2 is the isomer of TAPI-2. TAPI-2 (TNF Protease Inhibitor 2) is a broad-spectrum inhibitor of matrix metalloprotease (MMP), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM), with an IC50 of 20 μM for MMP. TAPI-2 blocks the entry of infectious SARS-CoV. | ||
| M2208 | Lomitapide | Others |
| AEGR-733, BMS-201038 | ||
| Lomitapide (AEGR-733, BMS-201038) is an inhibitor of microsomal triglyceride-transfer protein (MTP) wtih in vitro IC50 of 8 nM. | ||
| M4463 | Abametapir | MMP |
| HA-44; BRN 0123183; 5,5′-Dimethyl-2,2′-dipyridyl | ||
| Abametapir (HA-44, BRN 0123183) is an inhibitor of metalloproteinases critical for louse survival and egg development. | ||
| M27941 | AV-105 | Others |
| AV-105 is a Florbetapir (18F)-radiolabeled slyrylpyridine tosylate precursor extracted from patent WO2010078370A1, example 1.5. AV-105 can synthesize 18F-radiolabeled compounds, which are used for positron emission tomography (PET) imaging of neurodegenerative diseases of the brain. | ||
| M42567 | Motapizone | PDE |
| Motapizone (NAT 05-239) is a selective PDE3 inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
